Clinical Trial Update: Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial results assess a double-dose adenovirus-mediated adjuvant therapy given after liver transplantation in patients with advanced hepatocellular carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Double-dose adenovirus-mediated adjuvant therapy

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Liver Cancer, Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED